Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Fishman

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Oncogenesis|July 31, 2020
The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actionsChen Seraya-Bareket, Avivit Weisz, Elena Shinderman-Maman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center studyLimor Helpman, Tamar Perri, Natalie Lavee, et al.
Cancer Letters|April 27, 2023
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233]Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Gynecologic Oncology|May 30, 2018
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group StudyYael Yagur, Omer Weitzner, Ofer Gemer, et al.
Cancer Research|January 25, 2003
BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer casesSusan J Ramus, Paul D P Pharoah, Patricia Harrington, et al.
Gynecologic Oncology|July 18, 2021
Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional studyKhaled Ghoniem, Alyssa M Larish, Giorgia Dinoi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 18, 2025
Prognostic value of isolated tumor cells in sentinel lymph nodes in intermediate-risk endometrial cancer: results from an international, multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Oncogenesis|July 31, 2020
The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actionsChen Seraya-Bareket, Avivit Weisz, Elena Shinderman-Maman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center studyLimor Helpman, Tamar Perri, Natalie Lavee, et al.
Cancer Letters|April 27, 2023
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233]Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Gynecologic Oncology|May 30, 2018
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group StudyYael Yagur, Omer Weitzner, Ofer Gemer, et al.
Cancer Research|January 25, 2003
BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer casesSusan J Ramus, Paul D P Pharoah, Patricia Harrington, et al.
Gynecologic Oncology|July 18, 2021
Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional studyKhaled Ghoniem, Alyssa M Larish, Giorgia Dinoi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 18, 2025
Prognostic value of isolated tumor cells in sentinel lymph nodes in intermediate-risk endometrial cancer: results from an international, multi-institutional studyGiuseppe Cucinella, Gabriella Schivardi, Xun Clare Zhou, et al.
Pageof 8